Global Liver Failure Therapeutics Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Liver Failure Therapeutics

• 1.1 Definition of Liver Failure Therapeutics
• 1.2 Liver Failure Therapeutics Segment by Type
  • 1.2.1 Global Liver Failure Therapeutics Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Ornithine Phenylacetate
  • 1.2.3 MTL-CEBPA
  • 1.2.4 F-573
  • 1.2.5 BL-1220
  • 1.2.6 PP-100
  • 1.2.7 Others
• 1.3 Liver Failure Therapeutics Segment by Applications
  • 1.3.1 Global Liver Failure Therapeutics Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.4 Global Liver Failure Therapeutics Overall Market
  • 1.4.1 Global Liver Failure Therapeutics Revenue (2014-2025)
  • 1.4.2 Global Liver Failure Therapeutics Production (2014-2025)
  • 1.4.3 North America Liver Failure Therapeutics Status and Prospect (2014-2025)
  • 1.4.4 Europe Liver Failure Therapeutics Status and Prospect (2014-2025)
  • 1.4.5 China Liver Failure Therapeutics Status and Prospect (2014-2025)
  • 1.4.6 Japan Liver Failure Therapeutics Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Liver Failure Therapeutics Status and Prospect (2014-2025)
  • 1.4.8 India Liver Failure Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Liver Failure Therapeutics
• 2.3 Manufacturing Process Analysis of Liver Failure Therapeutics
• 2.4 Industry Chain Structure of Liver Failure Therapeutics

3 Development and Manufacturing Plants Analysis of Liver Failure Therapeutics

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Liver Failure Therapeutics Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Liver Failure Therapeutics
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Liver Failure Therapeutics Production and Capacity Analysis
• 4.2 Liver Failure Therapeutics Revenue Analysis
• 4.3 Liver Failure Therapeutics Price Analysis
• 4.4 Market Concentration Degree

5 Liver Failure Therapeutics Regional Market Analysis

• 5.1 Liver Failure Therapeutics Production by Regions
  • 5.1.1 Global Liver Failure Therapeutics Production by Regions
  • 5.1.2 Global Liver Failure Therapeutics Revenue by Regions
• 5.2 Liver Failure Therapeutics Consumption by Regions
• 5.3 North America Liver Failure Therapeutics Market Analysis
  • 5.3.1 North America Liver Failure Therapeutics Production
  • 5.3.2 North America Liver Failure Therapeutics Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Liver Failure Therapeutics Import and Export
• 5.4 Europe Liver Failure Therapeutics Market Analysis
  • 5.4.1 Europe Liver Failure Therapeutics Production
  • 5.4.2 Europe Liver Failure Therapeutics Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Liver Failure Therapeutics Import and Export
• 5.5 China Liver Failure Therapeutics Market Analysis
  • 5.5.1 China Liver Failure Therapeutics Production
  • 5.5.2 China Liver Failure Therapeutics Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Liver Failure Therapeutics Import and Export
• 5.6 Japan Liver Failure Therapeutics Market Analysis
  • 5.6.1 Japan Liver Failure Therapeutics Production
  • 5.6.2 Japan Liver Failure Therapeutics Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Liver Failure Therapeutics Import and Export
• 5.7 Southeast Asia Liver Failure Therapeutics Market Analysis
  • 5.7.1 Southeast Asia Liver Failure Therapeutics Production
  • 5.7.2 Southeast Asia Liver Failure Therapeutics Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Liver Failure Therapeutics Import and Export
• 5.8 India Liver Failure Therapeutics Market Analysis
  • 5.8.1 India Liver Failure Therapeutics Production
  • 5.8.2 India Liver Failure Therapeutics Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Liver Failure Therapeutics Import and Export

6 Liver Failure Therapeutics Segment Market Analysis (by Type)

• 6.1 Global Liver Failure Therapeutics Production by Type
• 6.2 Global Liver Failure Therapeutics Revenue by Type
• 6.3 Liver Failure Therapeutics Price by Type

7 Liver Failure Therapeutics Segment Market Analysis (by Application)

• 7.1 Global Liver Failure Therapeutics Consumption by Application
• 7.2 Global Liver Failure Therapeutics Consumption Market Share by Application (2014-2019)

8 Liver Failure Therapeutics Major Manufacturers Analysis

• 8.1 Alfact Innovation
  • 8.1.1 Alfact Innovation Liver Failure Therapeutics Production Sites and Area Served
  • 8.1.2 Alfact Innovation Product Introduction, Application and Specification
  • 8.1.3 Alfact Innovation Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 BioLineRx Ltd
  • 8.2.1 BioLineRx Ltd Liver Failure Therapeutics Production Sites and Area Served
  • 8.2.2 BioLineRx Ltd Product Introduction, Application and Specification
  • 8.2.3 BioLineRx Ltd Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Cell2B Advanced Therapeutics SA
  • 8.3.1 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Production Sites and Area Served
  • 8.3.2 Cell2B Advanced Therapeutics SA Product Introduction, Application and Specification
  • 8.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Conatus Pharmaceuticals Inc
  • 8.4.1 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Production Sites and Area Served
  • 8.4.2 Conatus Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Immune Pharmaceuticals Inc
  • 8.5.1 Immune Pharmaceuticals Inc Liver Failure Therapeutics Production Sites and Area Served
  • 8.5.2 Immune Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Mina Therapeutics Ltd
  • 8.6.1 Mina Therapeutics Ltd Liver Failure Therapeutics Production Sites and Area Served
  • 8.6.2 Mina Therapeutics Ltd Product Introduction, Application and Specification
  • 8.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Mylan NV
  • 8.7.1 Mylan NV Liver Failure Therapeutics Production Sites and Area Served
  • 8.7.2 Mylan NV Product Introduction, Application and Specification
  • 8.7.3 Mylan NV Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Ocera Therapeutics Inc
  • 8.8.1 Ocera Therapeutics Inc Liver Failure Therapeutics Production Sites and Area Served
  • 8.8.2 Ocera Therapeutics Inc Product Introduction, Application and Specification
  • 8.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 PledPharma AB
  • 8.9.1 PledPharma AB Liver Failure Therapeutics Production Sites and Area Served
  • 8.9.2 PledPharma AB Product Introduction, Application and Specification
  • 8.9.3 PledPharma AB Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Promethera Biosciences SA
  • 8.10.1 Promethera Biosciences SA Liver Failure Therapeutics Production Sites and Area Served
  • 8.10.2 Promethera Biosciences SA Product Introduction, Application and Specification
  • 8.10.3 Promethera Biosciences SA Liver Failure Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Silence Therapeutics Plc
• 8.12 Unicyte AG
• 8.13 Ventria Bioscience
• 8.14 Vital Therapies Inc

9 Development Trend of Analysis of Liver Failure Therapeutics Market

• 9.1 Global Liver Failure Therapeutics Market Trend Analysis
  • 9.1.1 Global Liver Failure Therapeutics Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Liver Failure Therapeutics Regional Market Trend
  • 9.2.1 North America Liver Failure Therapeutics Forecast 2019-2025
  • 9.2.2 Europe Liver Failure Therapeutics Forecast 2019-2025
  • 9.2.3 China Liver Failure Therapeutics Forecast 2019-2025
  • 9.2.4 Japan Liver Failure Therapeutics Forecast 2019-2025
  • 9.2.5 Southeast Asia Liver Failure Therapeutics Forecast 2019-2025
  • 9.2.6 India Liver Failure Therapeutics Forecast 2019-2025
• 9.3 Liver Failure Therapeutics Market Trend (Product Type)
• 9.4 Liver Failure Therapeutics Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Liver Failure Therapeutics Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List